Kumdee C, Yadee J, Pantumongkol W, Hadnorntun P, Kittiratchakul N, Leelahavarong P, Suchonwanich N, Ekakkararungroj C. Consequences and Enablers of the Selection of High-Cost Medicines to the National List of Essential Medicines Category E(2). J Health Syst Res [internet]. 2021 Dec. 30 [cited 2025 Jul. 12];15(4):456-7. available from: https://he04.tci-thaijo.org/index.php/j_hsr/article/view/3300